FGF2 and cancer: Moreover, bFGF was shown to enhance epithelial-to-mesenchymal transition (EMT) by inducing cancer-associated fibroblast (CAF) formation, with CAFs being key drivers of EMT due to their predominant overexpression of EMT-related markers such as Vimentin [46].